These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25382738)

  • 1. Chronic physical activity limits blood rheology alterations in transgenic SAD mice.
    Faes C; Charrin E; Connes P; Pialoux V; Martin C
    Am J Hematol; 2015 Feb; 90(2):E32-3. PubMed ID: 25382738
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy. Gene gemisch cures sickle cell in mice.
    Marshall E
    Science; 2001 Dec; 294(5550):2268. PubMed ID: 11743172
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell anemia as a rheologic disease.
    Horne MK
    Am J Med; 1981 Feb; 70(2):288-98. PubMed ID: 7008586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity limits pulmonary endothelial activation in sickle cell SAD mice.
    Aufradet E; Douillard A; Charrin E; Romdhani A; De Souza G; Bessaad A; Faes C; Bourgeaux V; Chirico EN; Canet-Soulas E; Pialoux V; Martin C
    Blood; 2014 Apr; 123(17):2745-7. PubMed ID: 24764563
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial blood pressure and hyperviscosity in sickle cell disease.
    Johnson CS
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):827-37, vi. PubMed ID: 16214646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise.
    Connes P; Hue O; Tripette J; Hardy-Dessources MD
    Clin Hemorheol Microcirc; 2008; 39(1-4):179-84. PubMed ID: 18503123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscosity of sickle disease and trait blood: changes with anesthesia.
    Laasberg LH; Hedley-Whyte J
    J Appl Physiol; 1973 Dec; 35(6):837-43. PubMed ID: 4765820
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic correction of sickle cell disease: insights using transgenic mouse models.
    Blouin MJ; Beauchemin H; Wright A; De Paepe M; Sorette M; Bleau AM; Nakamoto B; Ou CN; Stamatoyannopoulos G; Trudel M
    Nat Med; 2000 Feb; 6(2):177-82. PubMed ID: 10655106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.
    Rusanova I; Escames G; Cossio G; de Borace RG; Moreno B; Chahboune M; López LC; Díez T; Acuña-Castroviejo D
    Eur J Haematol; 2010 Dec; 85(6):529-37. PubMed ID: 20846340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transfusion on rheological properties of blood in sickle cell anemia.
    Jan K; Usami S; Smith JA
    Transfusion; 1982; 22(1):17-20. PubMed ID: 7064201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BCL11A controls the expression of the human fetal hemoglobin].
    Labie D
    Med Sci (Paris); 2012 Nov; 28(11):923-5. PubMed ID: 23171892
    [No Abstract]   [Full Text] [Related]  

  • 14. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
    Ye L; Chang JC; Lu R; Kan YW
    Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advances in sickle cell disease in the last decade.
    Shet AS; Thein SL
    Indian J Med Res; 2017 Jun; 145(6):708-712. PubMed ID: 29067969
    [No Abstract]   [Full Text] [Related]  

  • 17. Sickle cell and silent spleen.
    Tolar J
    Blood; 2015 Apr; 125(17):2589-90. PubMed ID: 25907900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulin therapy, blood rheology, and sickle cell anemia.
    Gangarossa S; Lucini NR
    Pediatr Hematol Oncol; 1993; 10(4):377-8. PubMed ID: 8292525
    [No Abstract]   [Full Text] [Related]  

  • 19. Human SS red cell rheological behavior in the microcirculation of cremaster muscle.
    Lipowsky HH; Usami S; Chien S
    Blood Cells; 1982; 8(1):113-26. PubMed ID: 6214291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheological aspects of sickle cell disease.
    Klug PP; Lessin LS; Radice P
    Arch Intern Med; 1974 Apr; 133(4):577-90. PubMed ID: 4594395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.